AstraZeneca Licenses Silicon Genetics' Gene Expression Enterprise Solution
16-Jan-2002 -
Redwood City, CA. - January 15, 2002 - Silicon Genetics, a leader in gene expression informatics solutions, today announced that AstraZeneca PLC has licensed its enterprise-wide products, GeneSpringTM, GeNetTM and Script EditorTM, designed for a genomics discovery platform.
Used together, ...
AstraZeneca
gene expression
gene expression profiling
+5